MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-76-0001832
Uniplus Biotech Private Limited
Uniplus Biotech Private Limited - pharma in Hapur, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹3.64 Cr
▼ 3% YoY
Net profit · FY 2024
₹8.5 Lakh
Net margin 2.3%
EBITDA · FY 2024
₹24.52 Lakh
EBITDA margin 6.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹7.48 Lakh
Issued & subscribed
Open charges
₹1.11 Cr
Secured borrowings
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
About Uniplus Biotech Private Limited
Data last updated:
Uniplus Biotech Private Limited is a private limited company based in Hapur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2010PTC039322. Its GSTIN is 09AABCU1414C1ZV (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹7.48 Lakh. It is led by directors Suman Lata and Niketa Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 76 Sanjay Vihar Meerut Road, Hapur, Uttar Pradesh, India – 245101.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.64 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹8.5 Lakh (net margin 2.3%) and EBITDA of ₹24.52 Lakh (EBITDA margin 6.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹1.11 Cr on record. Court records list 6 cases involving the company, including 6 filed against it; 3 cases are pending.
Uniplus Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-76-0001832). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233UP2010PTC039322
Registration Number 039322
Incorporation Date 22 January 2010
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-76-0001832
Key People
Suman Lata Director Niketa Tyagi Director Recognitions & Rankings of Uniplus Biotech
Contact details
Uniplus Biotech Private Limited's registered office is in Hapur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 76 Sanjay Vihar Meerut Road, Hapur, Uttar Pradesh, India – 245101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Uniplus Biotech Private Limited, buy the company report.
Comprehensive company report
Uniplus Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Uniplus Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Uniplus Biotech Private Limited, buy the company report.
Financials of Uniplus Biotech Private Limited
FY 2024 filings availableUniplus Biotech Private Limited reported revenue of ₹3.64 Cr (down 3% YoY) for FY 2024.
Revenue · FY 2024
₹3.64 Cr ▼ 3%
Net profit · FY 2024
₹8.5 Lakh margin 2.3%
EBITDA · FY 2024
₹24.52 Lakh margin 6.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 6%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 2%
3 years · compounded
▲ 7%
5 years · compounded
▲ 10%
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹24.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.5 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.7% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uniplus Biotech Private Limited, buy the company report.
Board of directors of Uniplus Biotech Private Limited
Uniplus Biotech has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suman Lata | Director | 15 Jun 2010 | 16 Years 4 Months | Current |
| Niketa Tyagi | Director | 10 Jun 2019 | 7 Years 4 Months | Current |
Auditor
Uniplus Biotech Private Limited is audited by UMESH MITTAL & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UMESH MITTAL & ASSOCIATES | FY 2022 | 005671C |
Shareholding
The shareholding of Uniplus Biotech Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Uniplus Biotech Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.11 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Feb 2025 | 101061244 | Canara Bank | ₹8 Lakh | Open | |
| 31 Dec 2021 | 100516998 | Canara Bank | ₹8.4 Lakh | Open | |
| 25 Mar 2021 | 100428613 | Others | ₹95 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Uniplus Biotech Private Limited has 6 court cases on record: 6 filed against it. 3 cases are pending and 3 are disposed.
Total cases
6
Filed against the company
6
Pending
3
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 5 | 3 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (CS(OS)) | Filed against the company by Abbott Healthcare Pvt Ltd | Disposed |
| District court, Kadapa, Andhra Pradesh | Criminal complaint | Filed against the company by The State of Andhra Pradesh, the Drugs Inspector, Kadapa. | Pending |
| District court, Hapur, Uttar Pradesh | Court case (Old Criminal Case) | Filed against the company | Pending |
| District court, Parbhani, Maharashtra | Court case (R.C.C.) | Filed against the company by The State of Maharashtra | Pending |
| District court, Nizamabad, Telangana | Criminal complaint | Filed against the company by The State of Telangana Rep by G.Prasad, Drugs Inspector, Nizamabad Urban | Disposed |
To see the full case history of Uniplus Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Uniplus Biotech Private Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 325 overdue payments to 6 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 6)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| M/S Shilpam Industries, Hapur | |||
| M/S. Harish Kumar Ravinder Kumar,Hapur | |||
| an individual supplier | |||
| an individual supplier | |||
| M/S Bajaj Grafix, Modinagar |
To see the full MSME payment records of Uniplus Biotech Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Uniplus Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCU1414C1ZV | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Uniplus Biotech Private Limited, buy the company report.
Recent activity
Uniplus Biotech Private Limited has 6 board changes on record since 2010: 2 appointments and 4 cessations. The latest: Niketa Tyagi ceased to be Additional Director on 30 Sep 2019.
Charges
A charge with Canara Bank amounted to Rs. 8.00 Lakh with Charge ID 101061244 was registered on 21 Feb 2025.
AGM
Uniplus Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Uniplus Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Charges
A charge with Canara Bank amounted to Rs. 8.40 Lakh with Charge ID 100516998 was registered on 31 Dec 2021.
Charges
A charge with Others amounted to Rs. 95.00 Lakh with Charge ID 100428613 was registered on 25 Mar 2021.
Ceased
Niketa Tyagi ceased to be Additional Director.
Ceased
Amit Tyagi ceased to be Director.
Appointed
Niketa Tyagi was appointed as Director.
Ceased
Atul Kumar Tyagi ceased to be Director.
Ceased
Bratpal Singh Tyagi ceased to be Director.
Appointed
Suman Lata was appointed as Director.
Incorporation
22 Jan 2010
Uniplus Biotech Private Limited was registered on 22 Jan 2010 with Roc Kanpur & aged 16 years 9 months as per MCA records.
Frequently asked questions
Uniplus Biotech is an active private limited company based in Hapur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 January 2010 (16+ years old) and is registered under CIN U24233UP2010PTC039322.
Uniplus Biotech has 2 current directors:
- Suman Lata - Director
- Niketa Tyagi - Director
The latest financial statements of Uniplus Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Uniplus Biotech is 09AABCU1414C1ZV, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Uniplus Biotech is U24233UP2010PTC039322. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uniplus Biotech has 6 court cases on record: 6 filed against it. 3 are pending. Most are in the district courts.
Uniplus Biotech was incorporated on 22 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
Niketa Tyagi ceased to be Additional Director on 30 Sep 2019. Amit Tyagi ceased to be Director on 10 Jun 2019. Niketa Tyagi was appointed as Director on 10 Jun 2019. Uniplus Biotech has 6 board changes on record in total.
Yes, Uniplus Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-76-0001832).
Uniplus Biotech has 11 MSME Form 1 returns on record between 2019 and 2023, listing 325 overdue payments to 6 micro and small suppliers. The latest return was filed on 13 Feb 2024.
The registered office of Uniplus Biotech is at C – 76 Sanjay Vihar Meerut Road, Hapur, Uttar Pradesh, India – 245101.